Open Access. Powered by Scholars. Published by Universities.®
Physical Sciences and Mathematics Commons™
Open Access. Powered by Scholars. Published by Universities.®
Articles 1 - 4 of 4
Full-Text Articles in Physical Sciences and Mathematics
Part I: Development Of Small-Molecule-Based Probes For The Vitamin D Receptor; Part Ii: Development Of A Scalable Manufacturing Process For Orcein Dye, Tania Roseann Mutchie
Part I: Development Of Small-Molecule-Based Probes For The Vitamin D Receptor; Part Ii: Development Of A Scalable Manufacturing Process For Orcein Dye, Tania Roseann Mutchie
Theses and Dissertations
PART I:The vitamin D receptor (VDR) is a ligand-dependent transcription factor and member of the nuclear hormone receptor superfamily. VDR is expressed in the epithelia of endocrine organs, digestive system, bronchi, kidneys, and thymus, as well as being present in leukocytes and bone cells. Cell proliferation, cell differentiation, and immunomodulation, along with calcium and phosphate homeostasis, are all processes regulated by the receptor. Within the cell, VDR can be membrane-bound or located in the nucleus. Nuclear localization of VDR transpires following the binding of vitamin D metabolites, the most active of which is 1α,25-dihydroxyvitamin D3 (calcitriol). Within the nucleus, interactions …
Part I. The Development Of Non-Secosteroidal Vitamin D Receptor Modulators Part Ii. The Development Of A Universal Gtp-Ase Assay, Kelly Ann Teske
Part I. The Development Of Non-Secosteroidal Vitamin D Receptor Modulators Part Ii. The Development Of A Universal Gtp-Ase Assay, Kelly Ann Teske
Theses and Dissertations
The vitamin D receptor is a nuclear hormone receptor that regulates cell proliferation, cell differentiation, calcium homeostasis and immunomodulation. The receptor is activated by the vitamin D metabolite, 1,25-dihydroxyvitamin D3, which induces a cascade of events including the recruitment of coactivators that activate transcription of specific VDR target genes. Thousands of VDR agonists have been synthesized based on the secosteroid scaffold of 1,25-dihydroxyvitamin D3. However, most of these ligands are metabolically unstable, have sub-optimal drug-like properties, and induce hypercalcemia in vivo. The limited numbers of VDR antagonists reported bear the same secosteroid scaffold and thus exhibit similar problems encountered by …
The Development Of Vdr-Coactivator Inhibitors And Their Evaluation Using Biochemical And Cell-Based Assays, Belaynesh Feleke
The Development Of Vdr-Coactivator Inhibitors And Their Evaluation Using Biochemical And Cell-Based Assays, Belaynesh Feleke
Theses and Dissertations
The vitamin D receptor (VDR) belongs to the family of nuclear receptors and plays a crucial role in many biological processes such as cell differentiation, cell proliferation and calcium homeostasis. VDR is a good pharmaceutical target for many diseases including cancer, metabolic disorders, skin diseases and cardiovascular diseases. Upon binding with its endogenous ligand calcitriol in the body, VDR undergoes a conformational change that disrupts the interaction with corepressor proteins and instead enables the interaction with coactivator proteins that mediated transcription. The goal of the research is the development of new small molecules that will selectively inhibit the interaction between …
Evaluation Of Vdr-Coactivator Inhibitors Using Biochemical And Cell-Based Assays, Athena Marie Baranowski
Evaluation Of Vdr-Coactivator Inhibitors Using Biochemical And Cell-Based Assays, Athena Marie Baranowski
Theses and Dissertations
ABSTRACT
EVALUATION OF VDR–COACTIVATOR INHIBITORS USING BIOCHEMICAL AND CELL–BASED ASSAYS
by
Athena Baranowski
The University of Wisconsin–Milwaukee, 2013
Under the Supervision of Dr. Alexander Arnold
The vitamin D receptor (VDR) is a ligand–dependent transcription factor, which belongs to the nuclear receptor superfamily. VDR–mediated gene regulation is governed by coregulators (coactivators and corepressors). VDR coregulator binding inhibitors (CBIs), which were discovered using high throughput screening (HTS), were evaluated using cell–based assays and biochemical assays to determine their ability to inhibit the interaction between VDR and steroid receptor coactivator–2 (SRC–2). Determining their ability to inhibit the VDR–SRC–2 interaction can lead to the …